REGENERON PHARMACEUTICALS (REGN)

US75886F1075 - Common Stock

894.86  +0.87 (+0.1%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
13.12B12.17B16.07B8.50B7.86B
Cost Of Goods
1.82B1.56B2.44B1.12B782.00M
Gross Profit
11.30B10.61B13.63B7.38B7.08B
Operating Expenses
7.07B5.62B4.69B3.80B4.87B
Research and Development
4.44B3.59B2.91B2.73B3.04B
Selling, General, and Administrative Expenses
2.63B2.12B1.82B1.35B1.83B
Operating Income
4.23B4.99B8.95B3.58B2.21B
Interest Income/Expense
172.20M-20.00M329.00M139.00M88.00M
Other Income/Expense
-20.00M140.00M50.00M95.00M131.00M
Non Recurring Items
-186.10M-255.00MN/AN/AN/A
Income Before Taxes
4.20B4.86B9.33B3.81B2.43B
Income Tax
245.70M520.00M1.25B297.00M313.00M
Net Income
3.95B4.34B8.07B3.51B2.12B
EBITDA
4.65B5.34B9.23B3.81B2.42B
 
Per Share Data
EPS Diluted Total Ops
34.7738.0572.0930.5418.39
Non GAAP EPS
43.7842.4071.3831.6524.64
 
Statistics
Gross Profit Margin
86.16%87.18%84.83%86.82%90.05%
Profit Margin
30.14%35.64%50.24%41.34%26.91%
Operating Profit Margin
32.27%41.03%55.67%42.10%28.11%

All data in USD

Charts